# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-21-001333
Filing Date
2021-02-09
Accepted
2021-02-09 09:09:40
Documents
66

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-1/A | gtbp_s1a.htm | S-1/A | 2401180
2 | OPINION OF BAKER & MCKENZIE LLP | gtbp_ex51.htm | EX-5.1 | 18864
3 | CONSENT OF SELIGSON & GIANNATTASIO, LLP | gtbp_ex23-1.htm | EX-23.1 | 4257
4 | IMAGE | gtbp_ex51000.jpg | GRAPHIC | 3984
5 | IMAGE | gtbp_s1000.jpg | GRAPHIC | 2685
6 | IMAGE | gtbp_s10001.jpg | GRAPHIC | 29192
7 | IMAGE | gtbp_s10002.jpg | GRAPHIC | 20611
8 | IMAGE | gtbp_s10003.jpg | GRAPHIC | 23227
9 | IMAGE | gtbp_s1001.jpg | GRAPHIC | 29310
10 | IMAGE | gtbp_s1002.jpg | GRAPHIC | 6309
11 | IMAGE | gtbp_s1013.jpg | GRAPHIC | 5497
12 | IMAGE | sidebar.jpg | GRAPHIC | 11303
| Complete submission text file | 0001654954-21-001333.txt |  | 5042159

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL INSTANCE DOCUMENT | gtbp-20200930.xml | EX-101.INS | 483148
14 | XBRL TAXONOMY EXTENSION SCHEMA | gtbp-20200930.xsd | EX-101.SCH | 31329
15 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | gtbp-20200930_cal.xml | EX-101.CAL | 43272
16 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | gtbp-20200930_def.xml | EX-101.DEF | 61263
17 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | gtbp-20200930_lab.xml | EX-101.LAB | 195588
18 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | gtbp-20200930_pre.xml | EX-101.PRE | 178733

Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-251311 | Film No.: 21604082
SIC: 2834 Pharmaceutical Preparations